Pamenter G; Ovari G; Kulkarni A; Williams-Fegredo T; Knevelman C; Mitrophanous K; Davies L; Foroutan F; Townsend M; Goldrick S; Bracewell DG · 2026 · Biotechnology and bioengineering
Paper
Generation of CAR-T cell therapies relies predominantly on lentiviral vectors (LVs). As in vivo CAR-T trials progress, demand for larger quantities of higher-potency LV is expected. However, primary capture by anion-exchange chromatography (AIEX) remains a major manufacturing bottleneck from use of adsorbents not tailored to LVs, leading to complex binding phenomena such as time-dependent product loss and a heterogenous two-peak elution profile arising from two distinct LV subpopulations (Peak 1 and Peak 2). Current industry practice is to collect both peaks to maximize total product recovery. Yet peak-specific differences in product potency and demand for higher purity products for use in in vivo CAR-T cell therapy will likely drive a need to separate these LV species. Electrospun nanofibers offer a promising next-generation adsorbent for addressing these challenges, making it essential to understand how Q-nanofiber design affects LV recovery and Peak 1/Peak 2 selectivity. This work indicates that Peak 1 and Peak 2 LVs differ in their T-cell transduction potency. Despite generating higher numbers of CD3 + GFP + T cells at low doses, Peak 1 sees reducing T-cell viability and %CD3 + GFP + cells at higher doses, likely from an inhibitory effect of VSV-G vesicles that are co-eluted with Peak 1 LV during AIEX. In contrast, Peak 2 LV maintained increasing %CD3 + GFP + T cells and high viability across doses. A Q-nanofiber adsorbent enabling high-recovery AIEX while increasing LV peak separation was therefore required to isolate the more potent Peak 2 LV subpopulation. Increasing nanofiber porosity (0.4-0.6 v/v) enhanced LV recovery by reducing time-dependent loss, whereas Peak Separation increased with ligand density and nanofiber diameter. An optimal Q-nanofiber structure was therefore identified and validated across two LV batches, achieving high recovery (64%-82%) while isolating Peak 2 LV from the major VSV-G elution.
Analysis
Preparing paper insights from the available abstract and paper details.
Discovery
Wu T; Lv B; Wang H; He G; Fu Y; Ji X; Zeng Y; Ni D; Qiu J; Hua K
Xudong Wang; Jin Zhang
Goldman C
Hofmann M; Unverdorben F; Pszolla MG; Aschmoneit N; Hutt M; Manz T; Schuster H; Hukelmann J; Acs A; Tenkerian C; Missel S; Mølhøj M; Schräder C; Wagner C; Maurer D; Bunk S; Reinhardt C
Pan D; Kumar A; Lipof JJ; Chung A; Wolf JL; Martin TG 3rd; Arora S; Sayre PH; Chari A
Wang L; Gong S; Wang J; Bao Y; Mei N; Lu X; Chen W; Xi L; Zhang H; Chen X; Ning P; Fan X; Wang H
Source record